Clinical Trials on Sexual Assault

Total 53577 results

Fundación Pública Andaluza para la Investigación...
Merck Sharp & Dohme LLC

Unknown

Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study (NEARQD)

HIV Infections

Spain
Avioq, Inc.
Duke Clinical Research Institute; University of North Carolina; Clinical Reference...

Completed

VioOne HIV Profile Supplemental Assay

HIV Infections

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission (OCTANE)

HIV Infections

South Africa, Botswana, Kenya, Malawi, Uganda, Zambia, Zimbabwe
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

HIV Infections

United States, Puerto Rico
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV (Nearly Naive)

HIV Infections

United States, Peru, Brazil
George Washington University

Terminated

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

HIV Infections

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

HIV Infections

Kenya
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)

HIV Infections
ViiV Healthcare
GlaxoSmithKline

Terminated

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

HIV Infections

United States, Taiwan, Peru, Canada, Thailand, Australia, Puerto Rico, Russian Federation, Argentina, Mexico, Colombia, South Africa, Chile
Kaiser Permanente
Merck Sharp & Dohme LLC

Completed

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects (CHEER)

HIV Infections

United States
Willem Daniel Francois Venter
Medical Research Council, South Africa

Completed

Evaluation of Low-dose Darunavir in a Switch Study (DRV)

HIV Infections

South Africa
Universidade Federal do Rio Grande do Norte

Completed

Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS

HIV Infections

Brazil
Bristol-Myers Squibb

Completed

PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) (PRINCE1)

HIV Infections

Thailand, Chile, Peru, Brazil, Mexico, South Africa
ViiV Healthcare
GlaxoSmithKline

Completed

Study on Pharmacokinetics

HIV Infections
ViiV Healthcare
GlaxoSmithKline

Completed

Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Response to Standard HIV Treatment in Bamako, Mali

HIV Infections

Mali
Institut de Recherche pour le Developpement
Ministry of Health, Thailand; Global Fund

Completed

Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

HIV Infections

Thailand
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Durability of Adherence in Self-Management of HIV (DASH)

HIV Infections

Peru, United States
Gilead Sciences

Completed

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

HIV Infections

United States, United Kingdom, Panama
University of Virginia

Completed

Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users (TEXTR34)

HIV Infections

United States
ANRS, Emerging Infectious Diseases
IMEA Leon M'Ba Foundation; Unit 1136 INSERM, Faculty of medecine, University...

Unknown

Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients (QUATUOR)

HIV Infections

France
Roxane Laboratories

Completed

Bioequivalency Study of Zidovudine Under Fasting Conditions

HIV Infections

United States
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers

HIV Infections

Russian Federation
Community Research Initiative of New England

Completed

Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors (DVD)

HIV Infections

United States
University of California, Davis
California HIV/AIDS Research Program

Completed

Impact of Antiretroviral Therapy on Cardiac Biomarkers

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

HIV Infections

United States
University of California, Davis

Completed

A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

HIV Infections

United States
Centre Hospitalier Intercommunal de Toulon La Seyne...
Merck Sharp & Dohme LLC; Abbott

Completed

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients (IntensVIH)

HIV Infections

France
Johns Hopkins University
University of California, Los Angeles

Completed

Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men

HIV Infections

United States
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Completed

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV (P1060)

HIV Infections

Uganda, India, Malawi, South Africa, Tanzania, Zambia, Zimbabwe
University of Medicine and Dentistry of New Jersey

Completed

Pain and Sensory Changes Assessment in HIV+ Patients

HIV Infections

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health... and other collaborators

Completed

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

HIV Infections

United States, Puerto Rico
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

HIV Infections
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention Interventions

HIV Infections

United States, Puerto Rico
Merck Sharp & Dohme LLC

Completed

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)

HIV Infections
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

HIV Infections

United States
Hoffmann-La Roche
Trimeris

Completed

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

HIV Infections

United States, Canada, Puerto Rico
Hoffmann-La Roche
Trimeris

Completed

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

HIV Infections

United States, Australia
Washington University School of Medicine
GlaxoSmithKline

Completed

Heart Function in HIV-Negative Children Exposed to HIV and HAART

HIV Infections

United States
Merck Sharp & Dohme LLC

Approved for marketing

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

HIV Infections
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women

HIV Infections

Zimbabwe, South Africa, Malawi, India, Botswana, Brazil, Peru, Thailand
Barbara Ensoli, MD
Italian Ministry of Foreign Affairs - General Direction for Cooperation and...

Completed

A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers (ISS T-003)

HIV Infections

South Africa
Rhode Island Hospital

Completed

Affect Management for Early Adolescents

HIV Infections

United States
Rigshospitalet, Denmark
University of Copenhagen

Completed

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

HIV Infections

Tanzania
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group

Completed

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

HIV Infections

United States, Puerto Rico
Hoffmann-La Roche
Trimeris

Completed

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

HIV Infections

United States
University of Miami
National Center for Complementary and Integrative Health (NCCIH)

Completed

Emotional Disclosure in HIV

HIV Infections

United States
University of Wisconsin, Madison

Completed

Relationship Between HIV-1 Subtype and ARV Response (RELATES)

HIV Infections

Uganda
Boehringer Ingelheim

Completed

Drug Drug Interaction of BI 201335 and Tenofovir

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

HIV Infections

United States

Clinical Trials on Sexual Assault

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations